Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 4,227 shares of the company’s stock in a transaction on Wednesday, October 25th. The stock was acquired at an average price of $5.42 per share, for a total transaction of $22,910.34. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Monday, October 23rd, Levin Capital Strategies, L.P. purchased 22,363 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. purchased 144,200 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. purchased 50,000 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $5.25 per share, for a total transaction of $315,000.00.
  • On Thursday, August 17th, Levin Capital Strategies, L.P. purchased 465 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $3.66 per share, for a total transaction of $1,701.90.
  • On Thursday, August 10th, Levin Capital Strategies, L.P. purchased 4,003,129 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $3.30 per share, for a total transaction of $13,210,325.70.
  • On Wednesday, August 9th, Levin Capital Strategies, L.P. purchased 1,549 shares of Fluidigm Corporation stock. The stock was acquired at an average price of $3.18 per share, for a total transaction of $4,925.82.

Fluidigm Corporation (NASDAQ FLDM) traded up 1.35% during mid-day trading on Friday, reaching $6.02. The company’s stock had a trading volume of 222,887 shares. Fluidigm Corporation has a 12 month low of $2.52 and a 12 month high of $8.69. The company’s market cap is $177.07 million. The stock’s 50 day moving average is $5.04 and its 200 day moving average is $4.50.

Fluidigm Corporation (NASDAQ:FLDM) last released its earnings results on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.02. Fluidigm Corporation had a negative return on equity of 121.04% and a negative net margin of 74.05%. The firm had revenue of $23.90 million for the quarter, compared to analyst estimates of $23.50 million. During the same quarter in the prior year, the firm posted ($0.63) earnings per share. The company’s quarterly revenue was down 15.2% on a year-over-year basis. Equities research analysts predict that Fluidigm Corporation will post ($1.95) EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/10/27/levin-capital-strategies-l-p-buys-4227-shares-of-fluidigm-corporation-fldm-stock.html.

A number of large investors have recently added to or reduced their stakes in FLDM. Wells Fargo & Company MN lifted its stake in Fluidigm Corporation by 15.0% in the first quarter. Wells Fargo & Company MN now owns 25,521 shares of the medical research company’s stock valued at $146,000 after buying an additional 3,327 shares during the period. Bank of New York Mellon Corp lifted its stake in Fluidigm Corporation by 20.5% in the first quarter. Bank of New York Mellon Corp now owns 206,578 shares of the medical research company’s stock valued at $1,175,000 after buying an additional 35,176 shares during the period. American International Group Inc. lifted its stake in Fluidigm Corporation by 7.1% in the first quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock valued at $102,000 after buying an additional 1,187 shares during the period. Wellington Management Group LLP lifted its stake in Fluidigm Corporation by 2.4% in the first quarter. Wellington Management Group LLP now owns 630,277 shares of the medical research company’s stock valued at $3,587,000 after buying an additional 14,814 shares during the period. Finally, Vanguard Group Inc. lifted its stake in Fluidigm Corporation by 1.7% in the first quarter. Vanguard Group Inc. now owns 1,181,883 shares of the medical research company’s stock valued at $6,725,000 after buying an additional 19,669 shares during the period. 88.61% of the stock is currently owned by hedge funds and other institutional investors.

Separately, ValuEngine upgraded shares of Fluidigm Corporation from a “strong sell” rating to a “sell” rating in a research report on Monday.

Fluidigm Corporation Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.